Once the standard, long acting, once daily baseline insulin, Lantus recently encountered significant competition. This opening of the insulin markets may finally bring some pricing relief to this still expensive necessity. For most Type 2 diabetics, the need for insulin marks the failure of diet and exercise to maintain normal body weight. By itself Lantus rarely suffices to control blood sugar.